CDK8 and medullary thyroid gland carcinoma: In 2020, Liu et al demonstrated that miR‐592 acts as an oncogene and promotes Medullary thyroid carcinoma (MTC) tumorigenesis by decreasing the expression of cyclin‐dependent kinase 8 (CDK8) [11].